How I Invest with David Weisburd

E239: FemHealth Ventures: Sara Crown Star on Redefining Success Beyond the Family Business

Nov 10, 2025
Sara Crown Star, a Venture Partner at FemHealth Ventures and President of SCS Innovations, dives into the transformative potential of women's health investments. She reveals how her family's legacy of integrity drives her philosophy. Sara discusses the revolutionary FemHealth Framework and highlights AI's role in improving fertility. She emphasizes the overlooked opportunities in women's health, from postpartum depression treatments to gaps in clinical trials. Personal stories weave through her insights on community impact and the importance of fostering independent thinkers.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

FemHealth Framework Reframes The Market

  • FemHealth Framework expands women's health to conditions unique to, mostly affecting, or affecting women differently.
  • FemHealth Ventures invests across drugs, diagnostics, devices, and digital/AI solutions to address that broader definition.
ANECDOTE

Creating A New Market With Thinx

  • Sara backed founders of Thinx to address incontinence and period products and served on their board until sale.
  • The exit to Kimberly-Clark validated creating new women's underwear and stress urinary incontinence markets.
ANECDOTE

Incision-Free Fibroid Treatment Succeeds

  • FemHealth invested in Gynasonics which built Sonata, an incision-free RF ablation device for fibroids.
  • The procedure shortens recovery, preserves fertility, and led to a 2025 acquisition by Hologic for $350M.
Get the Snipd Podcast app to discover more snips from this episode
Get the app